Symptoms

MSCs for Autism

Pioneering clinical trials, conducted at esteemed institutions across the United States, have unveiled the remarkable potential of stem cell therapy in enhancing the lives of children grappling with autism. These stem cells play a transformative role in nurturing the young minds, facilitating new blood vessel formation, fostering cell-to-cell communication, and orchestrating reprogramming. The results are awe-inspiring—children with heightened social interactions and newfound emotional expressions. A groundbreaking study conducted at Duke University stands as a testament to this transformative power. Among 180 children who received mesenchymal stem cells, behavioral metamorphoses were observed.

Protocol

Our meticulously crafted protocol unfolds over a gentle two-day period, designed for minimal patient invasiveness and swift recovery. The heart of our approach lies in the intravenous transplantation of cord tissue-derived MSCs, a procedure that takes approximately 45 minutes. Remarkably, patients can anticipate returning home just two days after their scheduled appointment.

Treatment Goals

At the core of our protocol is a profound aspiration—to significantly diminish chronic low-grade inflammation over an extended duration while rekindling the flames of emotional and social connections. The catalyst for these transformations is the enhancement of brain function, especially cell-to-cell communication.Stem cells possess an innate and extraordinary ability to journey to areas of injury and inflammation within the body. Scientific exploration has illuminated their capacity to orchestrate the rejuvenation of deteriorated tissues while harmonizing the immune system for the betterment of overall health.Depending on the specific ailment or the patient's initial condition, the benefits of stem cell therapy are multifaceted. They encompass the reduction of distressing symptoms, the deceleration of disease progression, and a tangible enhancement in the quality of life.entle two-day period, designed for minimal patient invasiveness and swift recovery. The heart of our approach lies in the intravenous transplantation of cord tissue-derived MSCs, a procedure that takes approximately 45 minutes. Remarkably, patients can anticipate returning home just two days after their scheduled appointment.